Home

Facility

Technologies

Contract Research

Contact Us
 

 
Welcome to Tergene
 

NEWS

 

Tergene, is a biotech company promoted by a scientist turned entrepreneur with a vision of providing quality human biologics.

Tergene is developing bio-conjugate platform technologies for novel vaccines and antibody drug conjugates. A basket of vaccines against bacterial pneumonia is under various stages of development.

Vision & Mission


Tergene's Vision is to deliver the best quality, cost-effective biologics to all categories of people.


Tergene's Mission is to improve the quality of life thus creating a healthier world.

 

 

 

 

"Affordable Vaccine platform for all"  Biospectrum magazine, March 2014. More...


23 Sep 2013
Tergene receives "DBT - BIRAC Innovator Award 2013" for the best innovation in the Healthcare sector. The award is in recognition of our innovative research towards Development of an Indigenous India specific 15-valent Pneumococcal Conjugate Vaccine.
More...


"Mission -Vaccine to fight pneumonia deaths" Biospectrum magazine, Nov 2011. More...

 

 

 

 Disclaimer                                                                                                                   2010 All Rights Reserved with Tergene Biotech